Chelsea Luther, MD | |
285 N Lilley Rd, Canton, MI 48187-3907 | |
(734) 495-1506 | |
(734) 495-1780 |
Full Name | Chelsea Luther |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 8 Years |
Location | 285 N Lilley Rd, Canton, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649629510 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 4301110305 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Joseph Mercy Hospital | Ann arbor, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dermatology Specialists Of Canton Pllc | 6507923976 | 16 |
News Archive
Cold and flu season is right around the corner, so it's time to start taking the steps to keep your body protected. Natural chelation and detoxification expert, Dr. Isaac Eliaz is re-shaping the way we look at detox methods by examining ways to enhance your body's natural defenses and prevent germs from attacking. Dr. Eliaz has profound information on various modalities of detoxification, including effective detox diets, integrative supplement formulas, lifestyle modifications, and detoxification therapies.
GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.
Two multi-gene tests designed to predict the risk of disease progression and response to chemotherapy in breast cancer produce broadly similar results for high- and low-risk patients, but do not always agree in their predictions for those at intermediate risk, a new analysis shows.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL (dasatinib) in Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukaemia (CP-CML) adult patients resistant or intolerant to Glivec (imatinib).
› Verified 7 days ago
Entity Name | Dermatology Specialists Of Canton Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003069014 PECOS PAC ID: 6507923976 Enrollment ID: O20090330000584 |
News Archive
Cold and flu season is right around the corner, so it's time to start taking the steps to keep your body protected. Natural chelation and detoxification expert, Dr. Isaac Eliaz is re-shaping the way we look at detox methods by examining ways to enhance your body's natural defenses and prevent germs from attacking. Dr. Eliaz has profound information on various modalities of detoxification, including effective detox diets, integrative supplement formulas, lifestyle modifications, and detoxification therapies.
GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.
Two multi-gene tests designed to predict the risk of disease progression and response to chemotherapy in breast cancer produce broadly similar results for high- and low-risk patients, but do not always agree in their predictions for those at intermediate risk, a new analysis shows.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL (dasatinib) in Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukaemia (CP-CML) adult patients resistant or intolerant to Glivec (imatinib).
› Verified 7 days ago
Entity Name | Dermatology & Phototherapy Center Of Brighton Plc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659624591 PECOS PAC ID: 7618114695 Enrollment ID: O20130510000391 |
News Archive
Cold and flu season is right around the corner, so it's time to start taking the steps to keep your body protected. Natural chelation and detoxification expert, Dr. Isaac Eliaz is re-shaping the way we look at detox methods by examining ways to enhance your body's natural defenses and prevent germs from attacking. Dr. Eliaz has profound information on various modalities of detoxification, including effective detox diets, integrative supplement formulas, lifestyle modifications, and detoxification therapies.
GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.
Two multi-gene tests designed to predict the risk of disease progression and response to chemotherapy in breast cancer produce broadly similar results for high- and low-risk patients, but do not always agree in their predictions for those at intermediate risk, a new analysis shows.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL (dasatinib) in Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukaemia (CP-CML) adult patients resistant or intolerant to Glivec (imatinib).
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Chelsea Luther, MD 43151 Dalcoma Dr Ste 4, Clinton Township, MI 48038-6306 Ph: (586) 286-8720 | Chelsea Luther, MD 285 N Lilley Rd, Canton, MI 48187-3907 Ph: (734) 495-1506 |
News Archive
Cold and flu season is right around the corner, so it's time to start taking the steps to keep your body protected. Natural chelation and detoxification expert, Dr. Isaac Eliaz is re-shaping the way we look at detox methods by examining ways to enhance your body's natural defenses and prevent germs from attacking. Dr. Eliaz has profound information on various modalities of detoxification, including effective detox diets, integrative supplement formulas, lifestyle modifications, and detoxification therapies.
GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.
Two multi-gene tests designed to predict the risk of disease progression and response to chemotherapy in breast cancer produce broadly similar results for high- and low-risk patients, but do not always agree in their predictions for those at intermediate risk, a new analysis shows.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL (dasatinib) in Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukaemia (CP-CML) adult patients resistant or intolerant to Glivec (imatinib).
› Verified 7 days ago
Dr. Thomas Powell Waldinger, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 285 N Lilley Rd, Canton, MI 48187 Phone: 734-495-1506 Fax: 734-829-2589 | |
Dr. Ann Ammond Lafond, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8584 N Canton Center Rd, Canton, MI 48187 Phone: 734-455-4917 | |
Kimberly Simons, PA Dermatology Medicare: Medicare Enrolled Practice Location: 285 N Lilley Rd, Canton, MI 48187 Phone: 734-495-1506 Fax: 734-495-1780 | |
Mrs. Sara Elizabeth Hayes, PA-C Dermatology Medicare: Medicare Enrolled Practice Location: 285 N Lilley Rd, Canton, MI 48187 Phone: 734-495-1506 Fax: 734-495-1780 | |
Dr. Ali A Berry, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 361 N Canton Center Rd, Canton, MI 48187 Phone: 734-495-1506 Fax: 734-495-1780 | |
Dr. David Blum, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 8584 N Canton Center Rd, Canton, MI 48187 Phone: 734-455-4917 | |
Andrea Elizabeth Schrieber, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 285 N Lilley Rd, Dermatology Specialists Of Canton, Canton, MI 48187 Phone: 734-495-1506 |